Your browser doesn't support javascript.
loading
Efficacy, safety, and dose adjustment of cyclophosphamide in lymphoma patients requiring hemodialysis.
Hamadah, Abdurrahman M; Thanarajasingam, Gita; Gharaibeh, Kamel A; Finnes, Heidi D; Thompson, Carrie A; Leung, Nelson.
Afiliação
  • Hamadah AM; a Division of Nephrology and Hypertension , Mayo Clinic , Rochester , MN , USA.
  • Thanarajasingam G; b Division of Hematology , Mayo Clinic , Rochester , MN , USA.
  • Gharaibeh KA; a Division of Nephrology and Hypertension , Mayo Clinic , Rochester , MN , USA.
  • Finnes HD; b Division of Hematology , Mayo Clinic , Rochester , MN , USA.
  • Thompson CA; b Division of Hematology , Mayo Clinic , Rochester , MN , USA.
  • Leung N; a Division of Nephrology and Hypertension , Mayo Clinic , Rochester , MN , USA.
Leuk Lymphoma ; 58(2): 457-460, 2017 02.
Article em En | MEDLINE | ID: mdl-27268591
Assuntos
Buscar no Google
Imprimir
XML
PubMed Links

Base de dados: MEDLINE Assunto principal: Diálise Renal / Antineoplásicos Alquilantes / Ciclofosfamida / Falência Renal Crônica / Linfoma Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2017 Tipo de documento: Article
Buscar no Google
Imprimir
XML
PubMed Links

Base de dados: MEDLINE Assunto principal: Diálise Renal / Antineoplásicos Alquilantes / Ciclofosfamida / Falência Renal Crônica / Linfoma Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2017 Tipo de documento: Article